Organization
Rochester Regional Health System
36 abstracts
Abstract
Real-world efficacy and adverse events of neoadjuvant immunotherapy in patients with early-stage triple-negative breast cancer: A multi-center experience.Org: Rochester Regional Health System, Pioneer Valley Oncology & Hematology,
Abstract
Prognostic factors of grade 4 IDH-mutant astrocytoma.Org: Mayo Clinic, Rochester Regional Health System, MN,
Abstract
First relapse in patients with multiple myeloma: Outcomes and predictors.Org: Mayo Clinic, Rochester Regional Health System, MN, Mayo Clinic Rochester, Rochester, MN, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ,
Abstract
The association between osimertinib and nutritional deficiency among patients with non-small cell lung cancer.Org: Unity Hospital, Rochester Regional Health System, Mount Auburn Hospital, Harvard Medical School, Cambridge University Hospitals NHS Foundation Trust,
Abstract
Navigating the intersection: Exploring racial disparities in major cardiovascular and cerebrovascular events among patients with hepatocellular carcinoma.Org: Landmark Medical Center, Woonsocket, River 3 Renal, New York Medical College - Saint Michael's Medical Center, Valhalla,
Abstract
Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants.Org: Department of Laboratory Medicine and Pathology, University of Washington, Mayo Clinic, Rochester Regional Health System, MN, Ambry Genetics,
Abstract
The effect of sodium glucose cotransporter-2 inhibitors on mortality and cardiovascular outcomes of patients with prostate cancer receiving luteinizing hormone releasing hormone agonists.Org: Department of Medicine, Icahn School of Medicine at Mount Sinai, Unity Hospital, Rochester Regional Health System, Rochester, NY, Mount Auburn Hospital,
Abstract
Direct oral anticoagulant versus low molecular weight heparin for venous thromboembolism in patients receiving immune checkpoint inhibitors.Org: Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, Department of Medicine, Icahn School of Medicine at Mount Sinai, Danbury Hospital,
Abstract
A phase 0/Ia study of BI 907828 concentrations in brain tissue and a nonrandomized, open-label, dose escalation study of BI 907828 in combination with radiotherapy in patients with newly diagnosed glioblastoma (GBM).Org: Mayo Clinic, Rochester Regional Health System, MN, Jacksonville, Flare Therapeutics,
Abstract
Patient-derived skin MicroOrganoSpheres and clinical response to immunotherapy.Org: Xilis, Durham Veteran Affairs Medical Center, NC Medical Research, Xilis Inc, Xilis, Inc.,
Abstract
The impact of sodium-glucose cotransporter-2 inhibitors on the outcome of patients with colorectal adenocarcinoma.Org: Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, National Taiwan University Hospital Yunlin Branch, Taipei, Taiwan,
Abstract
Comparison of synchronous neoplasms at colonoscopic diagnosis of early-onset versus average-onset colorectal cancer.Org: Mayo Clinic, Rochester Regional Health System, MN,
Abstract
Concordance among the three commercially available PD-L1 assays for esophageal squamous cell carcinoma.Org: Roche (China) Holding Ltd., Shanghai, China, Gracell Biotechnologies, Ltd., National Taiwan University Cancer Center/Hospital, Taipei, Taiwan, National Taiwan University Biomedical Park Hospital,
Abstract
Pirtobrutinib in covalent BTK-inhibitor (cBTKi) pre-treated mantle cell lymphoma (MCL): Updated results and subgroup analysis from the phase 1/2 BRUIN study with >3 years follow-up from start of enrollment.Org: Medical College of Wisconsin, Milwaukee, WI, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland, IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli” and Dipartimento di Medicina Specialistica,
Abstract
Impact of EML4-ALK fusion variant and co-occurring TP53 mutation on treatment duration of first-line next-generation ALK TKIs in ALK fusion+ NSCLC.Org: Mayo Clinic, Rochester Regional Health System, MN, Mayo Clinic College of Medicine, Takeda Development Center Americas, Inc., Lexington, MA, USA,
Abstract
Baseline autoantibody profiling in patients with NSCLC with pre-existing autoimmune diseases or who had received prior anti-PD-1 therapy before enrolling in the TAIL study.Org: Complejo Hospitalario Universitario Insular-Materno Infantil, Oncimmune Germany GmbH, Rochester Regional Health System, F. Hoffmann-La Roche AG, Genentech Inc.,
Abstract
Effect of DUAL pharmacological blockade of AURKA and PD-L1 pathways on plasticity and metastasis for triple negative breast cancer.Org: Mayo Clinic, Rochester Regional Health System, MN,
Abstract
Toxicity and outcomes of ipilimumab plus nivolumab in patients 80 years and older.Org: Mayo Clinic in Arizona, Phoenix Tissue Repair, Azidus Brasil, Mayo Clinic Arizona, Phoenix, AZ, Scottsdale,
Abstract
Analysis of different color unmixing methods for cMET-PDL1-EGFR multiplex assay.Org: Rochester Regional Health System, Santa Clara, CanSino Biologics, Tucson, AZ, Azidus Brasil,
Abstract
Colorectal cancer screening with blood-based tests: Estimated impact of a 1-, 2-, or 3-year screening interval compared with annual FIT and triennial mt-sDNA strategies.Org: University of Michigan, Ann Arbor, Millennium Pharmaceuticals, Division of Gastroenterology and Hepatology, Mayo Clinic, Mayo Clinic,
Abstract
Association of Medicaid expansion with timely receipt of treatment and survival among patients with HER2-enriched breast cancer.Org: American Cancer Society, Atlanta Cancer Care, Galderma R&D, Emory University School of Medicine, Roswell Park Comprehensive Cancer Center,
Abstract
The efficacy of cationic amphiphilic antihistamines on outcomes of patients with pancreatic ductal adenocarcinoma.Org: Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, National Taiwan University Hospital Yunlin Branch, Taipei, Taiwan,
Abstract
The timing of statin initiation on survival outcomes of cancer patients treated with immune checkpoint inhibitors: A retrospective cohort study.Org: Unity Hospital, Rochester Regional Health System, Department of Medical Education, Kuang Tien General Hospital, Mount Auburn Hospital,
Abstract
Remote evaluation of NAVIFY Oncology Hub using clinical simulation.Org: Prova Health, Stanford University School of Medicine, Epic Care, Menarini Group, Rochester Regional Health System,
Abstract
Hemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: A pharmacovigilance study from FDA Database.Org: Rochester General Hospital, Rochester, NY, Patan Academy of Health Sciences, Kathmandu, Nepal, Kathmandu, Nepal, University at Buffalo Jacobs School of Medicine and Biomedical Sciences,
Abstract
Growing wiser with age: Results from the ACCELERATE Fostering Age Inclusive Research Group clinical trial survey.Org: Accelerate Platform (Innovation for Children and Adolescents with Cancer), Institut Bergonié, Gustave Roussy Département d'Organisation du Parcours Patient, EV Pharma Solutions Ltd., Novartis Pharmaceuticals Corporation,
Abstract
Inclusive innovation: World Health Organization (WHO) task-shifting principles in community health workers living with disabilities through women’s cancer screening in the EMPOWER Program.Org: AMREF, Rochester Regional Health System,
Abstract
Outcomes of peritoneal metastases in mismatch repair deficient (dMMR) cancers treated with immune checkpoint inhibitors and variables associated with response.Org: Mayo Clinic Florida, Mayo Clinic, Mayo Clinic Jacksonville, Rochester Regional Health System, MN,
Abstract
Targeting HE4 for treatment of endometrial cancer using a novel small molecule inhibitor.Org: University of Rochester Medical School, Rochester Regional Health System, Nykode Therapeutics,
Abstract
Falls and hospitalization during chemotherapy in older women with early breast cancer.Org: City of Hope National Medical Center, Duarte, CA, University of Nebraska Medical Center, Omaha NE, Neurocentria,
Abstract
Return to work in breast cancer patients with and without pre-diagnosis psychological distress.Org: Mayo Clinic, Jacksonville, Flare Therapeutics, Rochester Regional Health System, MN,
Abstract
Anthracycline-related cardiotoxicity among patients with lymphoma: Systematic review and meta-analysis.Org: Mayo Clinic, Rochester Regional Health System, MN, Mayo Clinic-Rochester, City of Hope National Medical Center,
Abstract
Addressing the clinical trial selection process to improve representation by African American patients with breast cancer in cancer clinical trials.Org: Loyola University Medical Center, Maywood, IL, Il-Yang Pharmaceuticals, University of Rochester Medical School, Rochester Regional Health System,
Abstract
The impact of cationic amphiphilic antihistamines on patients with lung cancer receiving immunotherapy.Org: National Taiwan University Hospital Yunlin Branch, Mount Auburn Hospital, Harvard Medical School, Unity Hospital, Rochester Regional Health System,
Abstract
AROUND 60% OF PATIENTS WITH LONG-STANDING ACTIVE RHEUMATOID ARTHRITIS (RA) TREATED WITH RITUXIMAB REACH A PATIENT ACCEPTABLE SYMPTOM STATE (PASS) WITHIN 12 WEEKS, BUT THE RELATION WITH DISEASE ACTIVITY IS NOT DIRECT: DATA FROM THE SMART TRIAL Org: Rochester Regional Health System, Hôpital Cochin, Hôpital Lapeyronie, Hôpital Bois Guillaume, Hôpital Lyon Sud - HCL,
Abstract
BAFF AND FCGRIIIA POLYMORPISMS ARE PREDICTIVE FACTORS OF RESPONSE TO RITUXIMAB IN RA Org: Rochester Regional Health System, Docs International, Sèvres,